AI’s Role in Orthopedics: Advancements and Challenges

By Sumona Bose

January 8, 2024

Introduction

Artificial intelligence (AI) has rapidly evolved from a theoretical concept to a practical application with the help of affordable computational power and the availability of large data sets. In the healthcare field, AI has the potential to invigorate orthopedic treatment by addressing specific challenges such as image recognition, preoperative risk assessment, clinical decision-making, and analysis of massive data sets. A recent systematic review by Cabitza et al. highlighted the increasing number of initiatives that leverage AI to tackle orthopedic-specific problems. The review found that spine pathology, osteoarthritis (OA) detection and prediction, and imaging of bone and cartilage were the most studied topics. Machine learning (ML) techniques, particularly deep learning (DL) and support vector machines (SVMs), were the most frequently applied algorithms. Medical imaging data emerged as the most commonly used input source. This article will explore AI’s role in Orthopedics.

Figure 1: Remote patient monitoring. Data for health monitoring applications can be captured using a wide array of pervasive sensors that are worn on the body, implanted, or captured through ambient sensors, e.g., inertial motion sensors, electrocardiogram patches, smart watches, electroencephalograms, and prosthetics.

Discussing Challenges in AI Research

While the potential of AI in orthopedics is promising, there are challenges that need to be addressed. One of the main concerns is the accusation that AI in medicine provides no advantage over traditional statistics. However, this claim is unfounded as AI has proven to be effective in various medical applications. It is important to view traditional statistics and ML as lying on a spectrum rather than as distinct techniques.

To successfully implement AI in orthopedics, certain prerequisites need to be met. These include big accurate data sets, powerful computers, cloud computing, and open-source algorithmic development. However, there are additional challenges associated with AI research, such as privacy issues and biasing. If the data used to train AI models are biased, it can lead to systematic analytical mistakes. For example, if the training data predominantly consists of medical records of white men, the AI may make less accurate predictions for women, ethnic minorities, or other underrepresented groups.

Furthermore, AI lacks traits that are uniquely human, such as morality and intuition, making it prone to absurd mistakes. Adversarial attacks, which intentionally bias or force AI models to make errors, pose a significant threat to patient care and safety. These attacks can impact medical diagnosis, decision support, insurance claims, drug and device approvals, and clinical trials. AI’s role in Orthopedics highlight an important area in the medical industry where practical knowledge will meet theoretical insights.

Conclusion

Addressing these challenges requires careful consideration. Regulating AI too early may stifle innovation and result in inaccurate threat-based models and unwieldy regulatory structures. However, delaying regulation may leave healthcare systems vulnerable to adversarial attacks.

Reference url

Recent Posts

datopotamab deruxtecan approval
   

FDA Grants Datopotamab Deruxtecan Approval for HR-Positive Breast Cancer Treatment

đź’ˇ *What does the FDA’s latest approval mean for patients with advanced breast cancer?*
Datopotamab deruxtecan (Datroway) has just been approved for treating unresectable or metastatic HR-positive, HER2-negative breast cancer, offering new hope for patients who have already undergone multiple therapies. This breakthrough, stemming from the TROPION-Breast01 trial, showcases significant improvements in progression-free survival rates—a vital advancement in cancer care.

Curious about the implications of this treatment for both healthcare providers and patients? Dive into the full article to learn more!

#SyenzaNews #oncology #HealthcareInnovation

surrogate endpoints guidance
          

Surrogate Endpoints Guidance: New International Report Enhances HTA Practices

🔍 Are surrogate endpoints the key to shaping the future of health technology assessment?

A new report led by NICE reveals standardized guidance for using surrogate endpoints in health economic models, providing clarity and validation tools for HTA decisions. This collaborative effort across multiple global agencies aims to enhance predictions of long-term health benefits from short-term data.

Jump into the article to explore these impactful insights and learn how this guidance is set to improve health technology evaluations!

#SyenzaNews #HealthEconomics #HealthcareInnovation

cervical cancer prevention
    

Cervical Cancer Prevention Strategies: Insights from South African

🌍 Did you know South African women living with HIV face a significantly higher risk of cervical cancer?

Our latest article looks into the perspectives of women and their partners regarding innovative cervical cancer prevention strategies, including the acceptability of the intravaginal 5-fluorouracil (5FU) treatment. It highlights the critical role of education and counseling in improving screening uptake and treatment adherence.

Explore how we can enhance cervical health for vulnerable populations!

#SyenzaNews #globalhealth #oncology #HealthcareInnovation

When you partner with Syenza, it’s like a Nuclear Fusion.

Our expertise are combined with yours, and we contribute clinical expertise and advanced degrees in health policy, health economics, systems analysis, public finance, business, and project management. You’ll also feel our high-impact global and local perspectives with cultural intelligence.

SPEAK WITH US

CORRESPONDENCE ADDRESS

1950 W. Corporate Way, Suite 95478
Anaheim, CA 92801, USA

© 2025 Syenza™. All rights reserved.